π΅οΈ Varex Imaging Corp ($VREX)
SEC insider & ownership activity, last 12 months Β· CIK 1681622 Β· every row links its SEC filing
Over the last 12 months insiders sold $121K with no open-market buying against it. Jay K. Kunkel sold $82K in discretionary trades (AugβMar). No red-flag 8-Ks in the window.
π¨ 2 signals active β
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 2 sellers, $121K (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jay K. Kunkel | 0 | β | 2 | $82K | Mar 20, 2026 |
| Karen L. Aranki | 0 | β | 1 | $39K | Sep 19, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Pzena Investment Management LLC | 10.2% | 13G | Jul 3, 2025 | filing β | |
| Blackrock, Inc. | 8.2% | 13G | Apr 17, 2025 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Jay K. Kunkel | $50K | Mar 20, 2026 | filing β |
| Kimberley E. Honeysett | $47K | Dec 11, 2025 | filing β |
| Kimberley E. Honeysett | $41K | Nov 21, 2025 | filing β |
| Karen L. Aranki | $39K | Sep 19, 2025 | filing β |
| Jay K. Kunkel | $31K | Aug 14, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | May 7, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing β |
| Material agreement (1.01) | Mar 13, 2026 | filing β |
| Agreement terminated (1.02) | Mar 13, 2026 | filing β |
| New financial obligation (2.03) | Mar 13, 2026 | filing β |
| Other events (8.01) | Mar 13, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 13, 2026 | filing β |
| Shareholder vote (5.07) | Feb 12, 2026 | filing β |
| Earnings (2.02) | Feb 10, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing β |
| Earnings (2.02) | Nov 18, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 18, 2025 | filing β |
| Officer/director changes (5.02) | Sep 5, 2025 | filing β |
| Earnings (2.02) | Aug 7, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing β |